Cargando...

Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited

The treatment of myeloma has undergone extraordinary improvements in the past half century. These advances have been accompanied by a concern for secondary primary malignancies (SPMs). It has been known for decades that extended therapy with alkylating chemotherapy agents, such as melphalan, carries...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yang, Jay, Terebelo, Howard R., Zonder, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407607/
https://ncbi.nlm.nih.gov/pubmed/22851973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/801495
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!